Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 9/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | VDR | P11473 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12497039 | 0.83 | GRM5 (0.40) | GRM5GAAALDH1A1GLAHPGD | |
| SCHEMBL4562043 | 0.77 | GRM5 (0.44) | GRM5 | |
| SCHEMBL31366887 | 0.72 | GAA (0.53) | GAAALDH1A1HPGDVDRCYP1A2 | |
| SCHEMBL15470593 | 0.71 | RECQL (0.47) | GAAALDH1A1GLAHPGDL3MBTL1 | |
| SCHEMBL877768 | 0.70 | GAA (0.37) | GRM5GAAALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL877828 | 0.70 | GAA (0.37) | GRM5GAAALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL8706627 | 0.69 | RECQL (0.60) | GAAALDH1A1 | |
| SCHEMBL9316385 | 0.68 | GAA (0.49) | GAAALDH1A1HPGDL3MBTL1CYP1A2 | |
| SCHEMBL25282051 | 0.68 | ALDH1A1 (0.41) | GAAALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL31119039 | 0.66 | MEN1 (0.59) | GRM5GAAALDH1A1HPGDVDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140045873-A1 | NOVEL MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2014-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140045873-A1 | NOVEL MICROBIOCIDES | MSR1, CD209, C3AR1 | GRM5 1821/4885GAA 1009/4885ALDH1A1 884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.